Skip to main content
GNLX logo
GNLX
(NASDAQ)
Genelux Corporation
$2.72-- (--)
Loading... - Market loading

Genelux (GNLX) Stock Price & Financial Analysis

Genelux Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.63 - $2.79
52-Week High$8.54
52-Week Low$2.29
Open$2.64
Volume276.74K
Average Volume (3M)270.94K
Market Cap120.09M
Shares Outstanding44.15M
Price to Sales (P/S)14900.95
Price to Book (P/B)5.20
EV/EBITDA-3.30
Revenue (TTM)8.00K
Net Income (TTM)-33.58M
Free Cash Flow (TTM)-27.88M
EPS (TTM)$-0.85
Profit Margin-419762.50%
Operating Margin-432112.50%
Return on Equity (ROE)-146.51%
Debt to Equity0.11
50-Day MA$2.88
200-Day MA$3.33
52-Week Change-24.16%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Genelux

What is the current stock price for GNLX?

As of the latest trading session, GNLX stock trades at $2.68. The 52-week range is $2.29–$8.54, with a day range of $2.63–$2.79.

What is the P/E ratio for GNLX?

The P/E ratio (Price-to-Earnings) for GNLX is shown in the Key Statistics section. This valuation metric helps compare Genelux Corporation to industry peers.

Does GNLX pay dividends?

Genelux does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GNLX?

Analyst ratings and recommendations for GNLX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of GNLX?

Genelux's market capitalization is $118.3M, classifying it as a micro-cap company. Genelux operates in the Healthcare sector within the Biotechnology industry.